Transcat (TRNS) Q1 Revenue Rises 15%
Transcat (NASDAQ:TRNS), a provider of calibration services and test equipment distribution for regulated industries, released its fiscal first quarter 2026 results on August 7, 2025. Adjusted diluted earnings per share (Non-GAAP) reached $0.59 in Q1 FY2026, beating the analyst consensus of $0.535. Total revenue rose 14.6% from the prior year to $76.4 million in Q1 FY2026 but came in just below the expected $76.8 million mark. The company reported substantial growth in adjusted EBITDA and continued strong performance in acquisitions, despite a dip in net income and margin pressure in its service business, as service segment gross margin declined to 33.0%. The period reflected continued strategic progress, but also revealed areas to watch, particularly in service operating margins and integration costs.
Source: Analyst estimates provided by FactSet. Management expectations based on management's guidance, as provided in Q4 2025 earnings report.
Transcat operates as a specialized service and distribution provider to highly regulated sectors such as life sciences, pharmaceuticals, aerospace, and defense. It delivers calibration services, which ensure precision and compliance for measuring instruments, alongside distribution of test and measurement equipment. Its focus on serving industries subject to significant regulatory oversight provides predictable demand.
Source Fool.com
